Filing Flows › Neuronetics (STIM) › Recalls, complaints & regulation
Neuronetics (STIM): recalls and clinical trials
Neuronetics (STIM) beyond its filings: 1 recall in the last 12 months (1 in five years, 0 Class I); 4 active clinical trials.
Latest recalls
- 2026-10-21 · FDA device · NeuroStar Advanced Therapy System. Contains the NeuroStar HP Coil Assembly Part Number 81-01000-200. Affects the below NeuroStar Advanced Therapy Systems: 1.
Neuronetics' latest quarter
Neuronetics, Q3 2026: revenue $42.0M (+12% year over year), operating margin 1.3%, net loss $1.6M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
Questions
Has Neuronetics had any recalls?
1 recall on file over five years from the FDA, CPSC and NHTSA; 1 in the last 12 months.
How many clinical trials does Neuronetics have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.